Two cases of coma-associated bulla with eccrine gland necrosis in patients without drug intoxication.

Heterogeneity of human peripheral blood eosinophils: IHS is the cardiac involvement (15). A restrictive type variability in cell density and cytotoxic ability in relation of cardiomyopathy such as endomyocardial Ž brosis is to the level and the origin of hypereosinophilia. Int Arch characteristic (16). Moreover, IHS can also present with Allergy Appl Immunol 1983; 72: 336–346. a dilated cardiomyopathy and myocardial infarction, as 8. Prin L, Plumas J, Gruart V, Loiseau S, Aldebert D, Ameisen JC, et al. Elevated serum levels of soluble in our patient (1, 15). interleukin-2 receptor: a marker of disease activity in the In our opinion, this case shows that clinicians should hypereosinophilic syndrome. Blood 1991; 78: 2626–2632. be aware of organ involvement in patients with pro9. Touze JE, Fourcade L, Heno P, Mafart B, Mourot S. The tracted skin manifestations and blood eosinophilia. heart and the eosinophil. Med Trop 1998; 58: 459–464. Early echocardiography is strongly recommended. 10. Dubost-Brama A, Dubucquoi S, Janin A, Capron M, Delaporte E. Eosinophiles et peau: actualités. Ann Dermatol Venereol 1996; 123: 498–510. 11. Kazmierowski JA, Chusid MJ, Parrillo JE, Fauci AS, REFERENCES WolV SM. Dermatologic manifestations of the hypereosin1. Chusid MJ, Dale DC, West BC, WolV SM. The hypereosiophilic syndrome. Arch Dermatol 1978; 114: 531–535. nophilic syndrome: analysis of fourteen cases with review 12. Hilbert E, Detmar M, Gollnick H. Hypereosinophilic of the literature. Medicine (Baltimore) 1975; 54: 1–27. syndrome presenting as prurigo simplex subacuta in a 2. Dereure O, Meyer F, Ciurana AJ, Guilhou JJ. Dermatopatient with chronic hepatitis. Eur J Dermatol 1994; logical manifestations of idiopathic hypereosinophilic syn4: 545–547. drome: an unusual observation with protracted course and 13. Vonderheid EC, Bernengo MG, Burg G, Duvic M, Heald literature review. Eur J Dermatol 1994; 4: 110–116. P, Laroche L, et al. Update on erythrodermic cutaneous 3. Elkénavé FL, Calvo F, Erner J, Verola O, Rochet L, T-cell lymphoma: report of the International Society for Morel P, et al. Manifestations cutanées d’un syndrome Cutaneous Lymphomas. J Am Acad Dermatol 2002; 46: hyperéosinophile. Ann Dermatol Venereol 1986; 113: 95–106. 961–965. 14. Thestrup-Pedersen K, Halkier-Sorensen L, Sogaard H, 4. Lee ML, Fischer G, Gow E. Hypereosinophilic syndrome Zachariae H. The red man syndrome. Exfoliative dermapresenting with erythroderma. Australas J Dermatol 1988; titis of unknown etiology: a description and follow-up of 29: 95–101. 38 patients. J Am Acad Dermatol 1988; 18: 1307–1312. 5. May LP, Kelly J, Sanchez M. Hypereosinophilic syndrome 15. Parrillo JE, Borer JS, Henry WL, WolV SM, Fauci AS. with unusual cutaneous manifestations in two men with The cardiovascular manifestations of the hypereosinophilic HIV infection. J Am Acad Dermatol 1990; 23: 202–204. syndrome. Prospective study of 26 patients, with review 6. Smit AJ, van Essen LH, de Vries EG. Successful longof the literature. Am J Med 1979; 67: 572–582. term control of idiopathic hypereosinophilic syndrome 16. Presti C, Ryan T, Armstrong WF. Two-dimensional and with etoposide. Cancer 1991; 67: 2826–2827. Doppler echocardiographic Ž ndings in hypereosinophilic syndrome. Am Heart J 1987; 114: 172–175. 7. Prin L, Capron M, Tonnel AB, Bletry O, Capron A.